MAI Capital Management bought a new stake in Stericycle Inc (NASDAQ:SRCL) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,758 shares of the business services provider’s stock, valued at approximately $245,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Federated Investors Inc. PA grew its position in shares of Stericycle by 129.5% in the first quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock valued at $122,000 after purchasing an additional 1,178 shares during the last quarter. Whittier Trust Co. grew its position in shares of Stericycle by 362.6% in the second quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock valued at $129,000 after purchasing an additional 852 shares during the last quarter. Dupont Capital Management Corp grew its position in shares of Stericycle by 102.2% in the second quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock valued at $136,000 after purchasing an additional 1,056 shares during the last quarter. NumerixS Investment Technologies Inc grew its position in shares of Stericycle by 285.0% in the second quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock valued at $174,000 after purchasing an additional 1,995 shares during the last quarter. Finally, Intact Investment Management Inc. acquired a new stake in shares of Stericycle in the second quarter valued at about $202,000. Institutional investors own 95.47% of the company’s stock.

A number of equities research analysts recently weighed in on SRCL shares. BidaskClub downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Saturday, September 22nd. BMO Capital Markets cut their price target on shares of Stericycle from $71.00 to $63.00 and set a “market perform” rating for the company in a research note on Monday, August 6th. Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research note on Monday, October 1st. Robert W. Baird restated a “hold” rating and set a $70.00 price target on shares of Stericycle in a research note on Friday, August 3rd. Finally, Barrington Research set a $72.00 target price on shares of Stericycle and gave the company a “buy” rating in a research note on Friday, October 5th. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $71.29.

In other news, CFO Daniel Ginnetti sold 5,000 shares of the business’s stock in a transaction on Friday, July 27th. The shares were sold at an average price of $70.75, for a total value of $353,750.00. Following the completion of the transaction, the chief financial officer now owns 11,490 shares of the company’s stock, valued at approximately $812,917.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 10,060 shares of company stock valued at $707,912 in the last three months. 3.50% of the stock is owned by company insiders.

SRCL traded down $0.44 during trading on Friday, reaching $52.55. 996,613 shares of the company’s stock were exchanged, compared to its average volume of 900,560. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.81 and a current ratio of 0.81. Stericycle Inc has a fifty-two week low of $51.45 and a fifty-two week high of $76.73. The firm has a market capitalization of $5.04 billion, a PE ratio of 12.11, a P/E/G ratio of 1.38 and a beta of 0.35.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, August 2nd. The business services provider reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.04. Stericycle had a net margin of 5.03% and a return on equity of 14.04%. The firm had revenue of $883.30 million during the quarter, compared to analyst estimates of $896.62 million. During the same quarter in the previous year, the business earned $1.15 EPS. The business’s quarterly revenue was down 3.7% compared to the same quarter last year. Equities analysts forecast that Stericycle Inc will post 4.43 EPS for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

See Also: 52-Week High/Low

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.